Ticker
LABCompany Name
STANDARD BIOTOOLS INCSector
HealthcareIndustry
Diagnostics & ResearchExchange
NASDAQDate | Capital Expenditure | Free Cash Flow | Net Cash Flow - Operations |
---|---|---|---|
6/30/2025 | $ 12.58M | $ -105.46M | $ -92.88M |
3/31/2025 | $ 12.63M | $ -123.89M | $ -111.26M |
12/31/2024 | $ 8.36M | $ -151.81M | $ -143.45M |
9/30/2024 | $ 5.05M | $ -148.51M | $ -143.46M |
6/30/2024 | $ 3.7M | $ -130.7M | $ -127M |
3/31/2024 | $ 2.6M | $ -99.88M | $ -97.28M |
12/31/2023 | $ 2.83M | $ -46.12M | $ -43.29M |
9/30/2023 | $ 3.51M | $ -51.91M | $ -48.41M |
6/30/2023 | $ 3.87M | $ -65.47M | $ -61.61M |
3/31/2023 | $ 3.97M | $ -86.23M | $ -82.27M |
We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue
CF - Operations - CapEx
(=) FCF
FCF for STANDARD BIOTOOLS INC is calculated as follows: CF - Operations [ $ -17.2M ] - CapEx [ $ 2.51M ]
(=) FCF [ $ -19.71M ]
Minimum
Dec 31, 2024
Maximum
Sep 30, 2020
Average
Median
filtered constituents | 3.3K |
---|---|
min | $ -356.66M |
max | $ 390M |
average | $ 28.76M |
median | $ 461K |
std | $ 118M |